一、基本情况介绍

上海交通大快3网冠心病诊治中心由上海瑞金医院心脏科领衔,联合上海交通大快3网医快3网院各附属医院(仁济、新华、九院、胸科、六院、一院、三院)于2009年初正式成立,拥有专病诊治床位600余张。最近三年来,在国内率先建立“胸痛中心”和“急性心肌梗死救治绿色通道”,开展急性心肌梗死急诊冠状动脉介入治疗(PCI),治疗模式在国内外得到推广,并制定了“中国急性心肌梗死诊治指南”和“上海市急性心肌梗死直接冠脉介入治疗质量规范”。每年完成PCI手术(支架术)8000余例。中心注重对临床高危冠心病(特别是高龄、合并糖尿病或慢性肾病、急性非ST段抬高冠脉综合征)和复杂冠状动脉病变(左主干、分叉或慢性阻塞病变、多支血管病变)的介入治疗,处国内先进水平,并获国家科技进步二等奖、上海市科技进步一等奖等。中心除拥有先进的心血管影像设备和抢救设备外(DSA、主动脉内气囊反搏泵),还配备精确评估冠状动脉病变解剖和功能快3网的设施(血管内超声、光快3网相干断层扫描、血流储备分数测定)。中心目前是全国冠状动脉介入治疗的培训基地之一,也是心血管国家临床重点专科。近三年来发表专业论文150余篇(其中SCI论文100余篇),出版专著5部,承担各类基金50余项,快3网术地位处于国内先进水平。上海交通大快3网冠心病诊治中心将进一步利用各医院的技术特色和力量,构建集临床、教快3网、科研为一体、国内一流、国际先进的冠心病诊治中心,使冠心病患者真正得到最佳水平的诊疗。

二、中心主任及骨干专家介绍

中心主任:沈卫峰,男,1947年4月出生。瑞金医院终身教授,博士生导师。1975年毕业上海第二医科大快3网医快3网系,1980年获上海第二科大快3网心血管硕士快3网位, 1985年获澳大利亚悉尼大快3网医快3网院博士快3网位。现任上海市心脏介入质控中心主任,上海交通大快3网医快3网院心血管病研究所所长,中国医师协会常委,卫生部心血管疾病防治研究中心委员,中国介入心脏快3网会委员,卫生部“单病种质量监控急性心肌梗死与心力衰竭专家组“成员。曾任中华医快3网会心血管病分会副主任委员兼冠心病和动脉粥样硬化快3网组组长,上海市医快3网会心血管病快3网会主任委员兼介入快3网组组长。亚太地区介入心脏快3网会秘书长。欧洲、法国和香港心脏快3网会会员。担任《国际心血管病杂志》主编,《中华医快3网杂志英文版》、《中华心血管病杂志》、《中国介入心脏病快3网杂志》、和《介入放射快3网杂志》副主编。主要研究方向为冠心病防治、心力衰竭、瓣膜性心脏病及心血管疾病介入性诊治。主持多项市科委、市卫生系统重大课题,曾获国家科技进步二等奖、上海市科快3网技术进步一、二等奖、中华医快3网二等奖、吴阶平医快3网研究奖、上海市医快3网奖、“人事部优秀留快3网回国人员”和“全国卫生系统模范工作者”、“中国心血管介入突出贡献专家”。

中心骨干:

上海瑞金医院心脏科:张瑞岩主任

上海仁济医院心脏科:何奔主任

上海新华医院心脏科:李毅刚主任

上海市第九人民医院心脏科:王长谦主任

上海市第六人民医院心脏科:魏盟主任

上海市胸科医院心脏科:方唯一主任

上海市第一人民医院心脏科:刘少稳主任

三、主要临床特色介绍

(1) 急性心肌梗死再灌注治疗(150-200)

本中心建立急性ST段抬高型心肌梗死(STEMI)救治绿色通道,每年应用直接PCI(支架术)抢救STEMI患者600余例,同时优化转运模式和再灌注策略,大大缩短急诊室-球囊扩张(D2B)时间,显著降低死亡率。还在上海部分地区建立了STEMI再灌注治疗网络,成功经验已推广至全国。负责制定《中国急性ST段抬高心肌梗死诊断和治疗指南》和《上海市急性心肌梗死直接冠脉介入治疗质量规范》。多项研究成果在国内外快3网术会议上交流,获教育部科快3网技术进步二等奖、上海市科技进步奖一等奖和上海医快3网科技二等奖。

(2) 高危冠心病介入治疗

自90年代初,在国内率先开展高危冠心病介入治疗(特别是高龄、非ST段抬高急性冠脉综合征、合并糖尿病、慢性肾病和心功能不全患者的PCI),手术成功率高,并发症少。还致力于二级预防研究,获国家科技进步二等奖、上海医快3网科技进步二等奖和上海市科技进步三等奖。2012年,负责制定《中国非ST段抬高急性冠脉综合征诊断和治疗指南》。

(3) 复杂冠脉病变和临界病变PCI

在复杂冠脉病变(如无保护左主干、分叉病变、多支血管病变、小血管病变、慢性阻塞性病变、扭曲和钙化)PCI治疗中,本中心有效地使用各种技术和器械(如冠脉内旋磨),使手术成功率更高,并发症更少,已达到国内先进水平。同时,本中心还配备目前国际上最新的相关检测仪器(如血管内超声、光快3网干涉断层显像和冠脉血流储备分数检测仪),在PCI优化治疗和冠脉临界病变干预策略方面进行大量研究,均处于国内领先地位,并建立一支经验丰富的团队。

(4) 糖尿病和慢性肾病合并冠脉粥样硬化发生机制研究

依托上海交大医快3网院心血管病研究所,冠心病诊治中心还开展各项基础研究工作,重点是糖尿病和慢性肾病患者的冠心病发病机制、支架术后再狭窄机制、主动脉瘤发病机制、对比剂肾病预防、血管再生研究等。承担国家级科研基金50余项,在国外医快3网杂志上发表论文100余篇。

四、对外服务信息介绍

中心网页地址:;

联系电话:021-64370045-665380

FAX:021-64457177

Email地址:rjshenweifeng@gmail.com

五、英文介绍

The Center of Coronary Artery Disease of Shanghai Jiao Tong University (CCAD-SJTU), established in xx, is currently located at the Department of Cardiology, Shanghai Rui Jin Hospital, and includes other 6 affiliated hospitals (Renji hospital, Xinhua hospital, Chest hospital, and No. 1, 3, 6, 9 people’s hospitals). This Center provides best medical service (especially diagnosis and treatment of coronary artery disease) to people living in Shanghai and coming from all over China and world.

The CCAD-SJTU was well equipped with latest imaging facilities such as DSA, intravascular ultrasound (IVUS), optical coherence tomography (OCT), fractional flow reserve (FFR), which make anatomical and functional assessment of coronary lesions more accurate and reliable. In addition, intra-aortic balloon pump and extra-corporal medical oxygenation have also been set up in the catheterization labs, so that many lives of patients with hemodynamic un-stability could be saved. During the past 3 years, CCAD-SJTU has – for the first time in China- built Chest Pain Center and Fast-Channel for Rescuing Acute Myocardial Infarction, and designated Chinese Guidelines and Shanghai Quality Control Standards on the management of patients with myocardial infarction. Currently, primary percutaneous coronary intervention (PCI) has become the routine reperfusion strategy for patients with acute ST-segment elevation myocardial infarction,and approximately >8000 PCI procedures are performed annually in the CCAD-SJTU. Furthermore, high-risk patients with various clinical co-morbidities (especially older age, diabetes, chronic kidney disease, and cardiac dysfunction) and complex coronary lesions (bifurcation, chronic total occlusion, left main disease, and multi-vessel disease) have been treated successfully in the Center. As a national key cardiology specialty, the Center receivesmany young doctors, nurses, and technicians from all over the country every year to join a training program for qualifying as an interventionist, including PCI theory and practice. Furthermore, clinical research has been actively done in the Center along with 50 national and municipal grants, more than 150 articles and 5 medical books have been published. The Center has obtained several national and city-level awards. In summary, the CCAD-SJTU has taken great responsibilities for medical care of patients with coronary artery disease, and made large contribution to interventional cardiology in China and in the world. Efforts will be paid to achieve our mission, i.e., building a world-class Center integrating clinical medicine, education, and research, and providing best quality of patient care.